Fourth quarter revenue Up 24% to $20.3 million , gross profit margin of 61% Introduction of key performance indicators (KPIs) representing “land and expand” strategy with key customer accounts Cash flow positive from operations of $0.7 million in 2021 ROCHESTER, Mich. , Feb.
This is OptimizeRx’s largest enterprise-scale therapy initiation program launch to date ROCHESTER, Mich. , Feb. 22, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today
ROCHESTER, Mich. , Feb. 15, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced preliminary unaudited financial and operational results for the three months
ROCHESTER, Mich. , Feb. 10, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Thursday, February 24, 2022, at 4:30 p.m.
ROCHESTER, Mich. , Feb. 07, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that Will Febbo , OptimizeRx’s CEO, will participate in the upcoming Bank of
ROCHESTER, Mich. , Feb. 01, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced its vice president of data product, Mike Rousselle , has been named to MM+M’s
ROCHESTER, Mich. , Jan. 31, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy announced today that members of its leadership team will attend and present at the upcoming 11th
Improving the continuum of patient care through enabling technology at point-of-care remains a core company-wide mission ROCHESTER, Mich. , Jan. 18, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients
Panel to take place January 6, 2022 at 8:30am ET ROCHESTER, Mich. , Jan. 03, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, today announced that its chief executive
The solution uses the Company’s AI-driven Therapy Initiation and Persistence Platform to deliver tailored engagement leveraging real-world evidence insights in real-time ROCHESTER, Mich. , Dec. 29, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp . (the “Company”)(Nasdaq: OPRX), a leading provider of
